Objectives This scoping review aimed to suggest a Korean medicine approach by analyzing domestic and international clinical studies targeting the thoracic sympathetic ganglia. Methods This study was conducted based on Arksey and O'Malley's five steps and guided by the preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews checklist and appendix. We searched seven electronic databases for studies on thoracic sympathetic ganglia reported untill August 23, 2023. The search terms used were 'thoracic sympathetic chain', 'thoracic paravertebral sympathetic ganglia', and 'thoracic paravertebral ganglion'. Results One hundred twenty-nine studies were finally selected. 90 papers were noncomparative studies (69.8%). The most common disease or symptom was hyperhidrosis (n=109, 66.9%), associated with the T1-7 levels of thoracic sympathetic ganglia (n=107, 65.6%). There were 17 studies (13.2%) of percutaneous approaches targeting the thoracic sympathetic ganglia, five studies (3.1%) targeting the mid-lower thoracic sympathetic ganglia. Conclusions This study broadly analyzed trends in domestic and international research targeting the thoracic sympathetic ganglia and attempted to propose a future Korean medicine approach. Further studies are needed.